TrialTheScientificWorldJournal2012
Prognostic significance of serum proangiogenic molecules in patients with de novo non-Hodgkin lymphomas.
Pairaya Rujirojindakul et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it